Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

L-Dopa stimulates expression of the antioxidant enzyme NAD(P)H:quinone oxidoreductase (NQO) in cultured astroglial cells.

van Muiswinkel FL, Riemers FM, Peters GJ, LaFleur MV, Siegel D, Jongenelen CA, Drukarch B.

Free Radic Biol Med. 2000 Sep 1;29(5):442-53.

PMID:
11020666
2.

NAD(P)H:quinone oxidoreductase (NQO1) protects astroglial cells against L-dopa toxicity.

Drukarch B, Jongenelen CA, van Muiswinkel FL.

Adv Exp Med Biol. 2001;500:237-40. No abstract available.

PMID:
11764945
3.

Drug treatment of Parkinson's disease. Time for phase II.

Drukarch B, van Muiswinkel FL.

Biochem Pharmacol. 2000 May 1;59(9):1023-31.

PMID:
10704931
4.

Role of Nad(P)h: quinone oxidoreductase in the regulation of intracellular redox state.

Mohora M.

Rom J Intern Med. 2000-2001;38-39:33-50. Review.

PMID:
15529570
5.

Regulation of genes encoding NAD(P)H:quinone oxidoreductases.

Jaiswal AK.

Free Radic Biol Med. 2000 Aug;29(3-4):254-62. Review.

PMID:
11035254
6.

Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H:quinone oxidoreductase 1.

Foppoli C, De Marco F, Blarzino C, Perluigi M, Cini C, Coccia R.

Int J Biochem Cell Biol. 2005 Apr;37(4):852-63.

PMID:
15694844
7.

Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra.

van Muiswinkel FL, de Vos RA, Bol JG, Andringa G, Jansen Steur EN, Ross D, Siegel D, Drukarch B.

Neurobiol Aging. 2004 Oct;25(9):1253-62.

PMID:
15312971
8.

The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells.

Flier J, Van Muiswinkel FL, Jongenelen CA, Drukarch B.

Free Radic Res. 2002 Jun;36(6):695-9.

PMID:
12180195
9.

Effect of oxidative stress on UDP-glucuronosyltransferases in rat astrocytes.

Gradinaru D, Minn AL, Artur Y, Minn A, Heydel JM.

Toxicol Lett. 2012 Sep 18;213(3):316-24. doi: 10.1016/j.toxlet.2012.07.014. Epub 2012 Jul 27.

PMID:
22846377
10.
11.

Dopamine as a potent inducer of cellular glutathione and NAD(P)H:quinone oxidoreductase 1 in PC12 neuronal cells: a potential adaptive mechanism for dopaminergic neuroprotection.

Jia Z, Zhu H, Misra BR, Li Y, Misra HP.

Neurochem Res. 2008 Nov;33(11):2197-205. doi: 10.1007/s11064-008-9670-4. Epub 2008 Mar 27.

PMID:
18368484
12.
13.
14.

Depletion of glutathione up-regulates mitochondrial complex I expression in glial cells.

Vásquez OL, Almeida A, Bolaños JP.

J Neurochem. 2001 Mar;76(5):1593-6.

15.

Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism.

Cullen JJ, Hinkhouse MM, Grady M, Gaut AW, Liu J, Zhang YP, Weydert CJ, Domann FE, Oberley LW.

Cancer Res. 2003 Sep 1;63(17):5513-20.

16.

Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.

Shin JY, Park HJ, Ahn YH, Lee PH.

J Neurochem. 2009 Nov;111(4):1042-50. doi: 10.1111/j.1471-4159.2009.06381.x. Epub 2009 Sep 16.

17.

Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells.

Brar SS, Kennedy TP, Whorton AR, Sturrock AB, Huecksteadt TP, Ghio AJ, Hoidal JR.

Am J Physiol Cell Physiol. 2001 Mar;280(3):C659-76.

18.

Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin.

Valerio LG Jr, Kepa JK, Pickwell GV, Quattrochi LC.

Toxicol Lett. 2001 Feb 3;119(1):49-57.

PMID:
11275421
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk